EN
抗体药类似物
Research Grade Nivolumab
All
  • CatalogTD-HS870096
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBMS-936558,MDX-1106,ONO-4538,CAS:946414-94-4
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Nivolumab


Catalog No. TD-HS870096
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q15116
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BMS-936558,MDX-1106,ONO-4538,CAS:946414-94-4
Background Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HS870096_1.jpg
SEC-HPLC
 
  SEC-HPLC detection for Research Grade Nivolumab.
TD-HS870096_2.jpg
Bioactivity
 
Detects Human CD279/PDCD1/PD1 in indirect ELISAs.